
Opinion|Videos|March 25, 2024
Treatment Sequencing and Combination Therapies for MM
Carol Ann Huff, MD discusses how the approval of additional bispecific antibodies for multiple myeloma might change the treatment selection process, highlighting considerations for sequencing of agents and combination therapy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
Sonrotoclax Approval Delivers a Long-Awaited New Option for Relapsed or Refractory Mantle Cell Lymphoma
5


































































































































